U.S. Blood Collection Market Is Set For Lucrative Growth To 2030

U.S. Blood Collection Market Summary

The U.S. blood collection market size was estimated at USD 1.26 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.91% from 2025 to 2030. The increasing demand for blood collection products is largely fueled by the growing volume of diagnostic procedures that require blood samples. These include disease screenings, medication level monitoring, and other health assessments. Routine testing plays a vital role in the diagnosis, treatment planning, and ongoing management of chronic health conditions such as diabetes, cardiovascular disease, and cancer. Clinicians favor blood-based diagnostics due to their reliability, simplicity, and clinical relevance.

In addition, the rising incidence of both chronic and infectious diseases across the U.S. significantly contributes to the expanding use of blood collection devices. As the country becomes more globally connected, challenges stemming from economic integration, urbanization, industrial expansion, and large-scale migration have increased the burden of disease and public health risks. Conditions like diabetes, heart disease, and viral infections require frequent blood monitoring, thereby reinforcing the need for safe, efficient, and accurate blood collection tools to support ongoing care and clinical decision-making.

Key Market Trends & Insights

• In 2024, the venous blood collection segment held the largest share of the market, accounting for 82.44% of total revenue. It is also expected to grow at the fastest pace during the forecast period. This growth is attributed to the rising number of patients suffering from chronic illnesses that demand precise diagnostic tests and laboratory analysis. Venous sampling remains the preferred method for many healthcare providers and patients due to its ability to yield larger sample volumes, enabling comprehensive testing and greater diagnostic accuracy in a clinical setting.
• The diagnostics segment led the U.S. market in 2024 and is expected to maintain its position while recording the fastest CAGR over the coming years. Its continued dominance is supported by technological advancements that have dramatically improved diagnostic accuracy, efficiency, and speed. Modern diagnostic systems can now deliver timely results across a broad range of health conditions, which in turn improves patient outcomes and enables physicians to make informed treatment decisions. This segment’s growth also reflects the expanding role of precision medicine and preventive care in the U.S. healthcare ecosystem.
• Hospitals accounted for the largest end-use share in 2024, representing 28.01% of the market. This dominance is due to the high volume of diagnostic tests and medical procedures performed in hospital settings. The growing number of surgeries, including organ transplants and minimally invasive interventions such as angioplasty, has increased the need for blood transfusions and associated diagnostic support. Furthermore, trauma care and emergency room visits frequently require immediate blood analysis, strengthening the role of hospitals as key drivers in the blood collection device market.
• The age group between 19 to 65 years accounted for the largest market share in 2024 and is anticipated to grow at the fastest CAGR throughout the forecast period. This segment’s growth is driven by the rising prevalence of chronic health conditions within the working-age population. Diseases such as diabetes, cancer, and cardiovascular conditions require continuous monitoring and regular diagnostic testing, thereby increasing demand for reliable and accessible blood collection methods among this demographic.
• The urban segment led the U.S. blood collection market in 2024 and is expected to grow at the fastest CAGR during the forecast timeline. Urban regions are characterized by a highly developed hospital infrastructure and a dense concentration of diagnostic laboratories and healthcare providers. These areas also tend to have better access to advanced medical technologies and healthcare services, which supports higher testing volumes and an overall greater demand for blood collection devices.

Order a free sample PDF of the U.S. Blood Collection Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1.26 billion
• 2030 Projected Market Size: USD 2.08 billion
• CAGR (2025 - 2030): 8.91%

Key Companies & Market Share Insights

The market is highly competitive. Key companies deploy strategic initiatives, such as service development, launches, and sales & marketing strategies to increase product awareness and regional expansions and partnerships to strengthen their market share. Market players are also involved in conducting clinical testing of their procedures, patent applications, and increasing service penetration.

Key Players

• Sekisui Medical Co., Ltd.
• Becton, Dickinson and Company (BD)
• Greiner Bio-One
• QIAGEN
• Nipro Corporation
• Terumo Corporation
• Haemonetics Corp.
• Zhejiang Gongdong Medical Technology Co., Ltd
• Drucker Diagnostics
• AdvaCare Pharma

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

In conclusion, the U.S. blood collection market is experiencing consistent growth due to rising diagnostic needs, increasing chronic disease burden, and advancements in medical technology. The market is further strengthened by the dominance of venous collection and diagnostics segments, as well as the growing healthcare needs of adults aged 19 to 65. Urban regions continue to lead demand, driven by superior infrastructure and access to healthcare services. Hospitals remain central to this ecosystem, with rising surgical and trauma cases elevating blood collection needs. As healthcare moves toward preventive care, the importance of efficient blood collection systems will continue to grow.